| Identification | Back Directory | [Name]
L-Leucine, N-(2,5-dichlorobenzoyl)glycyl- | [CAS]
1824976-81-9 | [Synonyms]
L-Leucine, N-(2,5-dichlorobenzoyl)glycyl-
(2S)-2-{2-[(2,5-dichlorophenyl)formamido]acetamido}-4-methylpentanoic acid
(2S)-2-{2-[(2,5-Dichlorophenyl)formamido]acetamido}-4-methylpentanoic acid, CANDDY_MLN Tag | [Molecular Formula]
C15H18Cl2N2O4 | [MOL File]
1824976-81-9.mol | [Molecular Weight]
361.22 |
| Chemical Properties | Back Directory | [Boiling point ]
580.0±50.0 °C(Predicted) | [density ]
1.335±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [form ]
powder | [pka]
3.35±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
CANDDY (Chemical knockdown with Affinity aNd Degradation DYnamics) employs a bispecific molecule (target interactor + linker + CANDDY_MLN) th at degrades protein by direct recruitment to the proteasome. Shown to selectively and dose-dependently degrade KRAS G12D/V and MDM2 proteins and suppress their signaling without non-specific cytotoxic effects.
CANDDY, a protein-slaying approach, occurs without ubiquitination and bypasses the need for an E3 ligase. Has the potential to overcome the current limitations of proteolysis and to expand the application scope of degraders. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|